查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1941434

人工智慧药物发现市场规模、份额和趋势分析报告：按应用、治疗领域、最终用途、地区和细分市场预测，2026-2033年

Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Application, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

人工智慧药物研发市场概述

2025年全球人工智慧药物发现市场规模估计为23.5亿美元，预计到2033年将达到137.7亿美元。

预计从 2026 年到 2033 年，该市场将以 24.8% 的复合年增长率成长。对经济高效的药物开发的需求不断增长、药物再利用临床试验数量的增加以及慢性病患病率的上升是推动市场成长的关键因素。

此外，对精准医疗和标靶药物研发的日益重视，以及运算能力和云端基础设施的提升，也正在推动市场成长。对高性价比药物研发策略日益增长的需求，是人工智慧在药物发现产业发展的主要驱动力。根据2025年10月发表在《药理学前沿》（Frontiers in Pharmacology）上的报导，传统的药物研发需要超过10年的漫长週期，每种药物的成本通常超过20亿美元。人工智慧在药物发现和仿单标示外的应用，透过将已获已通过核准或在临床实验药物用于新的适应症，提供了一种避免早期安全性测试的策略。药物再利用可望降低风险，并将上市时间从3年缩短至12年，平均投资额为3亿美元。

人工智慧透过快速分析海量的生物学、化学和临床数据，识别新的药物-疾病关联，加速这一进程。这缩短了研发时间和成本，为製药公司和医疗机构提供了经济可行的替代方案，无需从头开始研发新药。将人工智慧与药物重定位结合，既能提高效率，又能降低相关风险和投资，有效解决了产业面临的关键挑战。人工智慧还能高效分析庞大的化合物库、生物医学文献、体学资料集和真实世界证据，从而识别出数量有限但机率极高的候选药物，无需进行大量的经验筛检，进一步增强了这一经济优势。

目录

第一章调查方法和范围

第二章执行摘要

3. 人工智慧在药物发现领域的市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
  • 案例研究结果
  • 用于药物发现的人工智慧市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析

第四章：人工智慧药物发现市场：按应用领域分類的估算与趋势分析

  • 全球人工智慧药物发现市场：按应用领域分析变化
  • 2021-2033年全球人工智慧药物发现市场规模及应用趋势
  • 药物的优化与再利用
  • 临床前试验
  • 其他的

第五章：人工智慧药物研发市场：按治疗领域分類的估算与趋势分析

  • 全球人工智慧药物研发市场：按治疗领域分析变化
  • 2021-2033年全球人工智慧药物研发市场规模及依治疗领域分類的趋势
  • 肿瘤学
  • 神经退化性疾病
  • 心血管疾病
  • 代谢性疾病
  • 感染疾病
  • 其他的

第六章：人工智慧药物发现市场：按最终用途分類的估算和趋势分析

  • 全球人工智慧药物研发市场：按最终用途分類的差异分析
  • 2021-2033年全球人工智慧药物研发市场规模及最终用途趋势
  • 製药和生物技术公司
  • CRO
  • 学术和研究机构
  • 其他的

第七章：人工智慧药物研发市场：区域估算与趋势分析

  • 2025年及2033年区域市占率分析
  • 区域市场概览
  • 市场规模、预测与趋势分析，2021-2033年
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 公司/竞争对手分类
  • 策略规划
  • 2025年商业市场分析
  • 公司简介/列表
    • Healx
    • BostonGene Corporation
    • BenevolentAI
    • Innophore
    • Delta4.ai
    • BioXcel Therapeutics Inc.
    • BullFrog AI Holdings, Inc.
    • Graphwise
    • Owkin, Inc
    • Insilico Medicine
    • IBM
    • Exscientia
    • Google（DeepMind）
    • BioSymetrics, Inc.
    • BPGbio Inc.（Berg Health）
    • Atomwise Inc.
    • Recursion
    • Aitia
    • Insitro
Product Code: GVR-4-68039-029-7

Artificial Intelligence In Drug Discovery Market Summary

The global artificial intelligence in drug discovery market size was estimated at USD 2.35 billion in 2025 and is projected to reach USD 13.77 billion by 2033, growing at a CAGR of 24.8% from 2026 to 2033. The rising demand for cost-effective drug development, the increasing number of clinical trials in drug repurposing, and the growing prevalence of chronic diseases are significant factors contributing to market growth.

In addition, the growing focus on precision medicine and targeted drug development, as well as improvements in computing power and cloud infrastructure, are other factors fueling market growth. The rising demand for cost-effective drug development strategies substantially drives the growth of artificial intelligence (AI) in the drug discovery industry. According to an article published in the Frontiers in Pharmacology Journal in October 2025, Traditional drug discovery involves lengthy timelines, often exceeding a decade, and costs frequently exceed USD 2 billion per drug. AI in drug discovery and repurposing offers a strategy to bypass early-stage safety testing by focusing on approved or investigational drugs for new indications. Drug repurposing is anticipated to reduce risks and bring drugs to the market in 3-12 years, with an average investment of USD 300 million.

AI accelerates this process by rapidly analyzing extensive biological, chemical, and clinical datasets to identify novel associations between drugs and diseases. This reduces development timelines and costs, offering pharmaceutical companies and healthcare providers an economically viable alternative to the development of new drugs. Integrating artificial intelligence with drug repurposing effectively addresses key industry challenges by enhancing productivity while reducing associated risks and investments. AI enhances this economic advantage by efficiently analyzing extensive chemical libraries, biomedical literature, omics datasets, and real-world evidence to identify a limited set of high-probability candidates, rather than supporting broad empirical screening.

Global Artificial Intelligence In Drug Discovery Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global artificial intelligence in drug discovery market report based on application, therapeutic area, end use, and region.

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug optimization and repurposing
  • Preclinical testing
  • Others
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Disease
  • Metabolic Diseases
  • Infectious Disease
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Application Segment
    • 1.2.2. Therapeutic Area
    • 1.2.3. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Artificial Intelligence in Drug Discovery Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for cost-effective drug development
      • 3.2.1.2. Increasing clinical trials in drug repurposing
      • 3.2.1.3. Growing focus on precision medicine and targeted drug development
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Highly regulated industry
      • 3.2.2.2. High computational costs and infrastructure requirements
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Case Study Insights
  • 3.4. Artificial Intelligence in Drug Discovery Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape
      • 3.4.2.6. Social Landscape

Chapter 4. Artificial Intelligence in Drug Discovery Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Artificial Intelligence in Drug Discovery Market Application Movement Analysis
  • 4.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Drug optimization and repurposing
    • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Preclinical testing
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Others
    • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Artificial Intelligence in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Artificial Intelligence in Drug Discovery Market Therapeutic Area Movement Analysis
  • 5.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Neurodegenerative Diseases
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Cardiovascular Disease
    • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Metabolic Diseases
    • 5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.8. Infectious Disease
    • 5.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Artificial Intelligence in Drug Discovery Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Artificial Intelligence in Drug Discovery Market End Use Movement Analysis
  • 6.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. Contract Research Organizations (CROs)
    • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Academic and Research Institutes
    • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Other
    • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Artificial Intelligence in Drug Discovery Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Healx
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. BostonGene Corporation
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. BenevolentAI
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Innophore
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Delta4.ai
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. BioXcel Therapeutics Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. BullFrog AI Holdings, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Graphwise
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Owkin, Inc
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Insilico Medicine
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. IBM
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Exscientia
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Google (DeepMind)
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. BioSymetrics, Inc.
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. BPGbio Inc. (Berg Health)
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Product benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. Atomwise Inc.
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Product benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. Recursion
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Product benchmarking
      • 8.4.17.4. Strategic initiatives
    • 8.4.18. Aitia
      • 8.4.18.1. Company overview
      • 8.4.18.2. Financial performance
      • 8.4.18.3. Product benchmarking
      • 8.4.18.4. Strategic initiatives
    • 8.4.19. Insitro
      • 8.4.19.1. Company overview
      • 8.4.19.2. Financial performance
      • 8.4.19.3. Product benchmarking
      • 8.4.19.4. Strategic initiatives

List of Tables

  • Table 1 List Of Abbreviations
  • Table 2 Global Artificial Intelligence In Drug Discovery Market, By Region, 2021 - 2033 (USD Million)
  • Table 3 Global Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 4 Global Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 5 Global Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 6 North America Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
  • Table 7 North America Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 8 North America Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 9 North America Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 10 US Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 11 US Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 12 US Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 Canada Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 14 Canada Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 15 Canada Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 16 Mexico Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 17 Mexico Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 18 Mexico Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 19 Europe Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
  • Table 20 Europe Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 21 Europe Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 22 Europe Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 23 UK Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 24 UK Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 25 UK Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 26 Germany Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 27 Germany Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 28 Germany Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 29 France Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 30 France Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 31 France Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 32 Italy Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 33 Italy Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 34 Italy Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 35 Spain Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 36 Spain Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 37 Spain Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 Denmark Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 39 Denmark Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 40 Denmark Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 41 Sweden Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 42 Sweden Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 43 Sweden Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 44 Norway Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 45 Norway Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 46 Norway Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 51 China Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 52 China Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 53 China Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Japan Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 55 Japan Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 56 Japan Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 57 India Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 58 India Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 59 India Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 60 South Korea Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 61 South Korea Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 62 South Korea Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 63 Australia Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 64 Australia Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 65 Australia Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 66 Thailand Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 67 Thailand Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 68 Thailand Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 69 Latin America Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 71 Latin America Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 72 Latin America Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 73 Brazil Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 74 Brazil Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 75 Brazil Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 76 Argentina Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 77 Argentina Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 78 Argentina Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 MEA Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
  • Table 80 MEA Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 81 MEA Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 82 MEA Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 South Africa Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 84 South Africa Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 85 South Africa Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 89 UAE Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 90 UAE Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 91 UAE Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Market formulation & validation
  • Fig. 5 Artificial intelligence in drug discovery market: Market outlook
  • Fig. 6 Artificial intelligence in drug discovery market: Segment outlook
  • Fig. 7 Artificial intelligence in drug discovery market: Competitive landscape outlook
  • Fig. 8 Parent market outlook
  • Fig. 9 Artificial intelligence in drug discovery market driver impact
  • Fig. 10 Artificial intelligence in drug discovery market restraint impact
  • Fig. 11 Artificial intelligence in drug discovery market: Application outlook and key takeaways
  • Fig. 12 Artificial intelligence in drug discovery market: Application movement analysis
  • Fig. 13 Drug optimization and repurposing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Preclinical testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Computer vision market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Artificial intelligence in drug discovery market: Therapeutic Area outlook and key takeaways
  • Fig. 18 Artificial intelligence in drug discovery market: Therapeutic Area movement analysis
  • Fig. 19 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Neurodegenerative diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Cardiovascular disease market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Metabolic diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Infectious disease market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Artificial intelligence in drug discovery market: End use outlook and key takeaways
  • Fig. 26 Artificial intelligence in drug discovery market: End use movement analysis
  • Fig. 27 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Contract research organizations (CROs) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Global Artificial intelligence in drug discovery market: Regional outlook and key takeaways
  • Fig. 32 Global Artificial intelligence in drug discovery market: Regional movement analysis
  • Fig. 33 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 US key country dynamics
  • Fig. 35 US market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Canada key country dynamics
  • Fig. 37 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Mexico key country dynamics
  • Fig. 39 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 UK key country dynamics
  • Fig. 42 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Germany key country dynamics
  • Fig. 44 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 France key country dynamics
  • Fig. 46 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Italy key country dynamics
  • Fig. 48 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Spain key country dynamics
  • Fig. 50 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark key country dynamics
  • Fig. 52 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Sweden key country dynamics
  • Fig. 54 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Norway key country dynamics
  • Fig. 56 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Japan key country dynamics
  • Fig. 59 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 China key country dynamics
  • Fig. 61 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 India key country dynamics
  • Fig. 63 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand key country dynamics
  • Fig. 65 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 South Korea key country dynamics
  • Fig. 67 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Australia key country dynamics
  • Fig. 69 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Brazil key country dynamics
  • Fig. 72 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Argentina key country dynamics
  • Fig. 74 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 South Africa key country dynamics
  • Fig. 77 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Saudi Arabia key country dynamics
  • Fig. 79 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 UAE key country dynamics
  • Fig. 81 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Kuwait key country dynamics
  • Fig. 83 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)